Impax Laboratories, Inc.
IPXL
IPXL was delisted on the 4th of May, 2018.
197 hedge funds and large institutions have $3.05B invested in Impax Laboratories, Inc. in 2015 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 64 increasing their positions, 80 reducing their positions, and 17 closing their positions.
172% more call options, than puts
Call options by funds: $12.9M | Put options by funds: $4.72M
135% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 17
50% more capital invested
Capital invested by funds: $2.03B → $3.05B (+$1.02B)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
11% more funds holding
Funds holding: 178 → 197 (+19)
20% less repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 80
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Pennant Capital Management
Summit,
New Jersey
|
+$59.4M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$33.3M |
| 3 |
Neuberger Berman Group
New York
|
+$32.6M |
| 4 |
HP
Hound Partners
New York
|
+$28.5M |
| 5 |
AG
Aravt Global
New York
|
+$14.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$45.6M |
| 2 |
Jennison Associates
New York
|
-$26.1M |
| 3 |
SPC
Slate Path Capital
New York
|
-$15.7M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$15M |
| 5 |
TA
Teachers Advisors
New York
|
-$10.8M |
IPXL Hedge Fund Activity: Q1 2015 in Review
197 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Impax Laboratories, Inc. (IPXL) for Q1 2015, worth a combined $3.05B — up 50% from $2.03B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new IPXL positions and 17 closed out — a net gain of 23 holders — while 64 added to existing stakes and 80 trimmed.
The largest buyer was Pennant Capital Management, adding an estimated $59.4M. The largest seller was Fidelity Investments, cutting an estimated $45.6M.
- 197 institutional investors held Impax Laboratories, Inc. (IPXL) as of Q1 2015, up from 178 in Q4 2014.
- Funds reported $3.05B of Impax Laboratories, Inc. stock for Q1 2015, up 50% quarter-over-quarter.
- 40 funds opened new Impax Laboratories, Inc. positions in Q1 2015 and 17 closed out, a net change of +23 holders.
- The largest Impax Laboratories, Inc. buyer in Q1 2015 was Pennant Capital Management, an estimated $59.4M added.
- The largest Impax Laboratories, Inc. seller in Q1 2015 was Fidelity Investments, an estimated $45.6M sold.
Based on aggregated 13F filings for Q1 2015.